The above diagram shows the color scheme of the layout in the main result page. The parent entities and officers are those entities, including individual and legal persons, have significant controls over the company in focus. The offspring entities and appointments are those entities that the company in focus can influence on.
Clicking the links on parent entities or officers, and offspring entities or managed companies will put them in focus and show upstream or downstream connections. In general, ascendant entities can be found by moving toward upstream, and descendant entities are by toward downstream. In this way, progenitor entities such as grandparent companies (parents of parent), sibling companies (children of parent), partner companies (parents of child), and progeny entities such as grandchild companies (children of child) can be found easily.
Parent entities and officers
Active
3
- 1
Mr Christoph Kerstein
Born in February 1961Individual (4 offsprings)Person with significant control
2016-04-06 ~ nowPE - Ownership of shares – 75% or more → CIF 0 - 2
Kueter, Beate
Born in November 1966Individual (1 offspring)Officer 2022-04-01 ~ nowOF - Director → CIF 0 - 3
Watkin, Stephen Allen
Born in March 1967Individual (4 offsprings)Officer 2022-09-28 ~ nowOF - Director → CIF 0
Ceased
6
- 1
Chisholm, David Murray
Company Director born in December 1931IndividualOfficer ~ 1997-12-31OF - Director → CIF 0Chisholm, David Murray
IndividualOfficer 1994-04-21 ~ 1997-12-31OF - Secretary → CIF 0 - 2
Forbes, Drummond Romary
Pharmacist born in May 1947Individual (1 offspring)Officer 1998-01-01 ~ 2002-05-07OF - Director → CIF 0Forbes, Drummond Romary
Individual (1 offspring)Officer 1998-01-01 ~ 2002-05-07OF - Secretary → CIF 0 - 3
Sefton, Susan Margaret
IndividualOfficer ~ 1993-04-21OF - Secretary → CIF 0 - 4
Kerstein, Christoph
Pharmacist born in February 1961Individual (4 offsprings)Officer 1997-01-23 ~ 2022-09-28OF - Director → CIF 0Kerstein, Christoph
Individual (4 offsprings)Officer 2002-05-08 ~ 2003-02-03OF - Secretary → CIF 0 - 5
Kerstein, Eike
Company Director born in September 1938IndividualOfficer ~ 2003-09-30OF - Director → CIF 0 - 6
Watkin, Stephen Allen
Managing Director born in March 1967Individual (4 offsprings)Officer 2003-02-03 ~ 2022-03-31OF - Director → CIF 0Watkin, Stephen Allen
Managing DirectorIndividual (4 offsprings)Officer 2003-02-03 ~ 2022-03-31OF - Secretary → CIF 0Mr Stephen Allen Watkin
Born in March 1967Individual (4 offsprings)Person with significant control 2016-04-06 ~ 2022-03-31PE - Has significant influence or control → CIF 0
Company in focus
HAMELN PHARMA LTD
Previous names
PHOENIX PHARMACEUTICALS LIMITED - 1998-08-20
HAMELN PHARMACEUTICALS LTD - 2020-04-01
PHOENIX PHARMA LTD. - 2004-10-01
Standard Industrial Classification
46460 - Wholesale Of Pharmaceutical Goods
Brief company account
Average Number of Employees
292024-01-01 ~ 2024-12-31
292023-01-01 ~ 2023-12-31
Turnover/Revenue
27,407,580 GBP2024-01-01 ~ 2024-12-31
24,513,442 GBP2023-01-01 ~ 2023-12-31
Cost of Sales
-15,557,427 GBP2024-01-01 ~ 2024-12-31
-14,057,371 GBP2023-01-01 ~ 2023-12-31
Gross Profit/Loss
11,850,153 GBP2024-01-01 ~ 2024-12-31
10,456,071 GBP2023-01-01 ~ 2023-12-31
Distribution Costs
-1,372,522 GBP2024-01-01 ~ 2024-12-31
-1,244,073 GBP2023-01-01 ~ 2023-12-31
Administrative Expenses
-6,303,403 GBP2024-01-01 ~ 2024-12-31
-5,632,814 GBP2023-01-01 ~ 2023-12-31
Operating Profit/Loss
4,174,228 GBP2024-01-01 ~ 2024-12-31
3,580,000 GBP2023-01-01 ~ 2023-12-31
Interest Payable/Similar Charges (Finance Costs)
-5,331 GBP2024-01-01 ~ 2024-12-31
-6,495 GBP2023-01-01 ~ 2023-12-31
Profit/Loss on Ordinary Activities Before Tax
4,168,897 GBP2024-01-01 ~ 2024-12-31
3,573,505 GBP2023-01-01 ~ 2023-12-31
Profit/Loss
2,924,724 GBP2024-01-01 ~ 2024-12-31
2,730,086 GBP2023-01-01 ~ 2023-12-31
Property, Plant & Equipment
63,481 GBP2024-12-31
76,461 GBP2023-12-31
Fixed Assets
63,481 GBP2024-12-31
76,461 GBP2023-12-31
Total Inventories
7,953,472 GBP2024-12-31
5,821,187 GBP2023-12-31
Debtors
Current
4,806,250 GBP2024-12-31
5,158,879 GBP2023-12-31
Cash at bank and in hand
2,724,779 GBP2024-12-31
3,862,306 GBP2023-12-31
Current Assets
15,484,501 GBP2024-12-31
14,842,372 GBP2023-12-31
Creditors
Current, Amounts falling due within one year
-3,288,362 GBP2023-12-31
Net Current Assets/Liabilities
10,885,508 GBP2024-12-31
11,554,010 GBP2023-12-31
Total Assets Less Current Liabilities
10,948,989 GBP2024-12-31
11,630,471 GBP2023-12-31
Net Assets/Liabilities
10,943,072 GBP2024-12-31
11,622,048 GBP2023-12-31
Equity
Called up share capital
2,000 GBP2024-12-31
2,000 GBP2023-12-31
2,000 GBP2023-01-01
Retained earnings (accumulated losses)
10,941,072 GBP2024-12-31
11,620,048 GBP2023-12-31
14,107,362 GBP2023-01-01
Equity
10,943,072 GBP2024-12-31
11,622,048 GBP2023-12-31
14,109,362 GBP2023-01-01
Profit/Loss
Retained earnings (accumulated losses)
2,924,724 GBP2024-01-01 ~ 2024-12-31
2,730,086 GBP2023-01-01 ~ 2023-12-31
Dividends Paid
Retained earnings (accumulated losses)
-3,603,700 GBP2024-01-01 ~ 2024-12-31
-5,217,400 GBP2023-01-01 ~ 2023-12-31
Dividends Paid
-3,603,700 GBP2024-01-01 ~ 2024-12-31
-5,217,400 GBP2023-01-01 ~ 2023-12-31
Property, Plant & Equipment - Depreciation Expense
20,490 GBP2024-01-01 ~ 2024-12-31
18,532 GBP2023-01-01 ~ 2023-12-31
Cash and Cash Equivalents
2,724,779 GBP2024-12-31
3,862,306 GBP2023-12-31
9,149,990 GBP2023-01-01
Wages/Salaries
2,167,338 GBP2024-01-01 ~ 2024-12-31
1,965,146 GBP2023-01-01 ~ 2023-12-31
Social Security Costs
265,611 GBP2024-01-01 ~ 2024-12-31
263,163 GBP2023-01-01 ~ 2023-12-31
Staff Costs/Employee Benefits Expense
2,573,822 GBP2024-01-01 ~ 2024-12-31
2,346,067 GBP2023-01-01 ~ 2023-12-31
Director Remuneration
452,276 GBP2024-01-01 ~ 2024-12-31
375,667 GBP2023-01-01 ~ 2023-12-31
Deferred Tax Expense/Credit Relating to Origination/Reversal Timing Differences
-2,506 GBP2024-01-01 ~ 2024-12-31
Tax Expense/Credit at Applicable Tax Rate
1,042,224 GBP2024-01-01 ~ 2024-12-31
839,774 GBP2023-01-01 ~ 2023-12-31
Dividends Paid on Shares
3,603,700 GBP2024-01-01 ~ 2024-12-31
5,217,400 GBP2023-01-01 ~ 2023-12-31
Property, Plant & Equipment - Gross Cost
Motor vehicles
13,291 GBP2024-12-31
13,291 GBP2023-12-31
Furniture and fittings
481,558 GBP2024-12-31
474,048 GBP2023-12-31
Property, Plant & Equipment - Gross Cost
676,174 GBP2024-12-31
668,664 GBP2023-12-31
Property, Plant & Equipment - Accumulated Depreciation (Not Including Impairment)
Motor vehicles
13,291 GBP2023-12-31
Furniture and fittings
442,411 GBP2023-12-31
Property, Plant & Equipment - Accumulated Depreciation (Not Including Impairment)
592,203 GBP2023-12-31
Property, Plant & Equipment - Increase From Depreciation Charge for Year
Owned/Freehold
20,490 GBP2024-01-01 ~ 2024-12-31
Property, Plant & Equipment - Accumulated Depreciation & Impairment
Motor vehicles
13,291 GBP2024-12-31
Furniture and fittings
456,617 GBP2024-12-31
Property, Plant & Equipment - Accumulated Depreciation & Impairment
612,693 GBP2024-12-31
Property, Plant & Equipment
Furniture and fittings
24,941 GBP2024-12-31
31,637 GBP2023-12-31
Finished Goods/Goods for Resale
7,953,472 GBP2024-12-31
5,821,187 GBP2023-12-31
Trade Debtors/Trade Receivables
Current
3,431,405 GBP2024-12-31
2,858,534 GBP2023-12-31
Other Debtors
Current
1,294,886 GBP2024-12-31
2,277,560 GBP2023-12-31
Prepayments/Accrued Income
Current
79,959 GBP2024-12-31
22,785 GBP2023-12-31
Trade Creditors/Trade Payables
Current
2,930,294 GBP2024-12-31
2,036,741 GBP2023-12-31
Taxation/Social Security Payable
Current
692,253 GBP2024-12-31
651,247 GBP2023-12-31
Other Creditors
Current
5,003 GBP2024-12-31
6,977 GBP2023-12-31
Accrued Liabilities/Deferred Income
Current
971,443 GBP2024-12-31
593,397 GBP2023-12-31
Creditors
Current
4,598,993 GBP2024-12-31
3,288,362 GBP2023-12-31
Net Deferred Tax Liability/Asset
-5,917 GBP2024-12-31
-8,423 GBP2023-12-31
-3,520 GBP2023-01-01
Profit/Loss - Increase/Decrease in Net Deferred Tax Liability from Amount Recognised
2,506 GBP2024-01-01 ~ 2024-12-31
-4,903 GBP2023-01-01 ~ 2023-12-31
Deferred Tax Liabilities
Accelerated tax depreciation
-5,917 GBP2024-12-31
-8,423 GBP2023-12-31
Number of Shares Issued (Fully Paid)
Class 1 ordinary share
2,000 shares2024-12-31
2,000 shares2023-12-31
Par Value of Share
Class 1 ordinary share
1.002024-01-01 ~ 2024-12-31
Future Minimum Lease Payments Under Non-cancellable Operating Leases
Amounts falling due within one year
221,718 GBP2024-12-31
65,072 GBP2023-12-31
Between one and five year
740,526 GBP2024-12-31
76,995 GBP2023-12-31
More than five year
796,725 GBP2024-12-31
Future Minimum Lease Payments Under Non-cancellable Operating Leases
1,758,969 GBP2024-12-31
142,067 GBP2023-12-31
HAMELN PHARMA LTD
InfoPHOENIX PHARMACEUTICALS LIMITED - 1998-08-20HAMELN PHARMACEUTICALS LTD - 1998-08-20PHOENIX PHARMA LTD. - 1998-08-20Registered number 01034697
Nexus Hurricane Road, Gloucester Business Park, Gloucester, Gloucestershire GL3 4AGPRIVATE LIMITED COMPANY incorporated on 1971-12-14 (53 years 11 months). The company status is Active.The last date of confirmation statement was made at 2025-05-13CIF 0
Offspring entities and appointments
Active
0
- Not found in our database.
The content of this website is protected by AgonGuard.
© 2022-2025 Polylogarithmic Technology Ltd (Registered in England and Wales No. 14256313). All rights reserved.
Contains public sector information retrieved at 12 November 2025 and
licensed under the Open Government Licence v3.0.